LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 49.63 27.76 2908 4818 0.6036 0.8688
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 51.33 27.76 166 5117 0.0324 0.2682
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 51.33 27.76 2534 5117 0.4952 0.8217
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 51.33 27.76 1938 5117 0.3787 0.7579
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 51.33 27.76 2159 5117 0.4219 0.7833
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 51.33 27.76 385 5117 0.0752 0.4182
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 51.33 27.76 3057 5117 0.5974 0.8677
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 53.04 27.76 190 5365 0.0354 0.2882
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 53.04 27.76 2653 5365 0.4944 0.8229
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 53.04 27.76 1937 5365 0.3610 0.7489
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 53.04 27.76 2201 5365 0.4102 0.7786
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 53.04 27.76 429 5365 0.0800 0.4341
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 53.04 27.76 3225 5365 0.6010 0.8703
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 54.74 27.76 211 5606 0.0376 0.3033
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 54.74 27.76 2788 5606 0.4973 0.8256
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 54.74 27.76 1995 5606 0.3558 0.7476
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 54.74 27.76 2250 5606 0.4013 0.7752
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 54.74 27.76 463 5606 0.0826 0.4441
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 54.74 27.76 3355 5606 0.5984 0.8703
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 56.45 27.76 219 5745 0.0381 0.3080
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 56.45 27.76 2891 5745 0.5032 0.8292
MN20160318_Q01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 56.45 27.76 2045 5745 0.3559 0.7487
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 56.45 27.76 2351 5745 0.4092 0.7807
MN20160318_Q01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 56.45 27.76 480 5745 0.0835 0.4484
MN20160318_Q01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 56.45 27.76 3493 5745 0.6080 0.8747
MN20160318_Q01
I21